Literature DB >> 3039515

Cell transformation and tumor induction by Abelson murine leukemia virus in the absence of helper virus.

P L Green, D A Kaehler, R Risser.   

Abstract

We investigated the role of the Moloney helper virus, Moloney murine leukemia virus (Mo-MuLV), in cell transformation and tumor induction by the defective Abelson murine leukemia virus (Ab-MuLV). A molecular clone of Ab-MuLV (P160 strain) was transfected into the psi 2 packaging cell line, and helper virus-free Ab-MuLV (psi 2) was harvested from the supernatant medium. Ab-MuLV (psi 2) was as efficient as helper virus-containing Ab-MuLV (Mo-MuLV) in the transformation of primary bone marrow cells in vitro. Inoculation of weanling BALB/c mice with Ab-MuLV (psi 2) induced nonthymic pre-B-cell lymphomas with high efficiency and short latency (28 days). Adult BALB/c mice were less sensitive to tumor induction by a factor of 100. Ab-MuLV (psi 2) did not induce tumors in weanling C57BL/6 mice, unlike Ab-MuLV (Mo-MuLV). Examination of the proviral integration pattern in Ab-MuLV (psi 2)-induced tumor cell DNA revealed that each of the tumors contained a single integrated provirus. Immunoprecipitation of viral-encoded proteins in helper virus-free tumor cell lines detected the P160 Ab-MuLV-transforming protein; however, no trace of the gag, pol, and env helper virus-encoded proteins was found. Our results indicate that integration and expression of a single Ab-MuLV genome is sufficient for efficient transformation of primary bone marrow cells by Ab-MuLV in vitro and tumor induction in susceptible mice. However, the helper virus may contribute to tumor induction in weanling resistant mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039515      PMCID: PMC298977          DOI: 10.1073/pnas.84.16.5932

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Characterization of mouse cellular deoxyribonucleic acid homologous to Abelson murine leukemia virus-specific sequences.

Authors:  B Dale; B Ozanne
Journal:  Mol Cell Biol       Date:  1981-08       Impact factor: 4.272

2.  Mapping cell surface antigens on mouse pre-B cell lines.

Authors:  J P McKearn; N Rosenberg
Journal:  Eur J Immunol       Date:  1985-03       Impact factor: 5.532

3.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  The mouse c-abl locus: molecular cloning and characterization.

Authors:  J Y Wang; F Ledley; S Goff; R Lee; Y Groner; D Baltimore
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

6.  Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.

Authors:  C G Orosz; N E Zinn; R G Olsen; L E Mathes
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

7.  Thymocyte subsets transformed by Abelson murine leukemia virus.

Authors:  W D Cook
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

8.  Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region.

Authors:  H T Cuypers; G Selten; W Quint; M Zijlstra; E R Maandag; W Boelens; P van Wezenbeek; C Melief; A Berns
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

9.  Phenotypic variation in clonal Abelson virus lymphoma cells.

Authors:  P L Green; W W Lamph; J Dudley; A Arfsten; R Risser; L L Lanier; N L Warner; J S Tung; M P Scheid
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

10.  Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.

Authors:  E P Reddy; M J Smith; A Srinivasan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  10 in total

1.  Carboxyl-terminal determinants of Abelson protein important for lymphoma induction.

Authors:  K Parmar; R C Huebner; N Rosenberg
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

2.  Decreased virus population diversity in p53-null mice infected with weakly oncogenic Abelson virus.

Authors:  Erica Marchlik; Richard Kalman; Naomi Rosenberg
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  Distinct helper virus requirements for Abelson murine leukemia virus-induced pre-B- and T-cell lymphomas.

Authors:  Y Poirier; P Jolicoeur
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

4.  Multiple steps are required for the induction of tumors by Abelson murine leukemia virus.

Authors:  P L Green; D A Kaehler; L M Bennett; R Risser
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

5.  Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.

Authors:  G D Holland; M J Henkemeyer; D A Kaehler; F M Hoffmann; R Risser
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

6.  Identification of a common helper provirus integration site in Abelson murine leukemia virus-induced lymphoma DNA.

Authors:  Y Poirier; C Kozak; P Jolicoeur
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

7.  Expression of v-rel induces mature B-cell lines that reflect the diversity of avian immunoglobulin heavy- and light-chain rearrangements.

Authors:  C F Barth; E H Humphries
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

8.  Thymic targets for Abelson murine leukemia virus are early gamma/delta T lymphocytes.

Authors:  G D Holland; K Ito; D A Kaehler; S Tonegawa; R Risser
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

9.  An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.

Authors:  H Rosenbaum; A W Harris; M L Bath; J McNeall; E Webb; J M Adams; S Cory
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

Review 10.  AHI-1: a novel signaling protein and potential therapeutic target in human leukemia and brain disorders.

Authors:  Sharmin Esmailzadeh; Xiaoyan Jiang
Journal:  Oncotarget       Date:  2011-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.